Longevity · Metabolic health
Metformin for longevity: does the evidence hold up?
Metformin is one of the most-prescribed drugs on earth, cheap, and unusually safe. Observational studies in diabetics have consistently shown lower rates of cardiovascular disease, cancer, and dementia than in non-diabetics. That paradox is the entire premise of the TAME trial — 'Targeting Aging with Metformin' — currently the largest human anti-aging RCT ever run.
Mechanism
Metformin activates AMPK (energy sensing), mildly inhibits mitochondrial complex I, and reshapes the gut microbiome. Downstream: improved insulin sensitivity, reduced hepatic gluconeogenesis, lower systemic inflammation.
Menopause-specific rationale
- Reverses some of the insulin resistance that emerges in perimenopause
- Reduces visceral fat accumulation
- Observational data suggests reduced risk of postmenopausal breast cancer
- May improve cognitive resilience (mixed data)
The exercise blunting question
Konopka's 2019 study is real and worth respecting. Practical workarounds: dose metformin with your largest meal away from exercise (e.g., dinner if you train in the morning), or cycle off during focused training blocks.
Frequently asked questions
Does metformin extend lifespan?
Not confirmed in humans. Observational data is suggestive but confounded. The TAME trial (~3,000 participants) will provide the first randomized answer.
What dose of metformin is used for longevity?
Most off-label longevity protocols use 500–1,000 mg extended-release once daily with dinner. Standard diabetes doses go up to 2,000 mg/day.
Does metformin blunt exercise adaptations?
A 2019 study (Konopka et al.) showed metformin blunted mitochondrial adaptations to aerobic training in older adults. This is the most legitimate concern about longevity use — many physicians now dose it away from workouts or cycle it.
Is metformin safe for postmenopausal women?
Yes, with normal kidney function. It reduces visceral fat, improves insulin sensitivity, and may lower breast cancer risk in observational data.
Metformin vs berberine?
Metformin has 60+ years of safety data and stronger effect on glucose. Berberine is over-the-counter but with a smaller effect size and less regulatory oversight.
Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.
Request your Longevity Consult →Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service
Medically reviewed by Kindr Health Clinical Team · Last reviewed 2026-06-19. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.